Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Costa

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Plos One|August 28, 2018
The microbiota of hematophagous ectoparasites collected from migratory birdsFrancesco Cerutti, Paola Modesto, Francesca Rizzo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2018
Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?Roberto Buzzetti, Valeria Galici, Natalia Cirilli, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 15, 2012
Stunting is an independent predictor of mortality in patients with cystic fibrosisGiuseppe Vieni, Simona Faraci, Mirella Collura, et al.
Genome Biology|October 18, 2008
MINT and IntAct contribute to the Second BioCreative challenge: serving the text-mining community with high quality molecular interaction dataAndrew Chatr-aryamontri, Samuel Kerrien, Jyoti Khadake, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 13, 2017
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trialEugenia Bruzzese, Valeria Raia, Eliana Ruberto, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2020
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More <i>F508del</i> Alleles: Interim Results of an Open-Label Phase 3 Clinical TrialMatthias Griese, Stefano Costa, Rachel W Linnemann, et al.
BMC Gastroenterology|December 19, 2014
A point-of-care test for facing the burden of undiagnosed celiac disease in the Mediterranean area: a pragmatic design studyStefano Costa, Luca Astarita, Mongi Ben-Hariz, et al.
Journal of Clinical Gastroenterology|December 20, 2017
Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary CareRiccardo Scoglio, Gianluca Trifirò, Antonino Sandullo, et al.
Frontiers in Pediatrics|February 23, 2023
Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imagingNicholas Landini, Pierluigi Ciet, Hettie M Janssens, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 21, 2022
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell backgroundValeria Tomati, Stefano Costa, Valeria Capurro, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Plos One|August 28, 2018
The microbiota of hematophagous ectoparasites collected from migratory birdsFrancesco Cerutti, Paola Modesto, Francesca Rizzo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 20, 2018
Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?Roberto Buzzetti, Valeria Galici, Natalia Cirilli, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 15, 2012
Stunting is an independent predictor of mortality in patients with cystic fibrosisGiuseppe Vieni, Simona Faraci, Mirella Collura, et al.
Genome Biology|October 18, 2008
MINT and IntAct contribute to the Second BioCreative challenge: serving the text-mining community with high quality molecular interaction dataAndrew Chatr-aryamontri, Samuel Kerrien, Jyoti Khadake, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 13, 2017
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trialEugenia Bruzzese, Valeria Raia, Eliana Ruberto, et al.
American Journal of Respiratory and Critical Care Medicine|September 24, 2020
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More <i>F508del</i> Alleles: Interim Results of an Open-Label Phase 3 Clinical TrialMatthias Griese, Stefano Costa, Rachel W Linnemann, et al.
BMC Gastroenterology|December 19, 2014
A point-of-care test for facing the burden of undiagnosed celiac disease in the Mediterranean area: a pragmatic design studyStefano Costa, Luca Astarita, Mongi Ben-Hariz, et al.
Journal of Clinical Gastroenterology|December 20, 2017
Diagnostic Yield of 2 Strategies for Adult Celiac Disease Identification in Primary CareRiccardo Scoglio, Gianluca Trifirò, Antonino Sandullo, et al.
Frontiers in Pediatrics|February 23, 2023
Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imagingNicholas Landini, Pierluigi Ciet, Hettie M Janssens, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 21, 2022
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell backgroundValeria Tomati, Stefano Costa, Valeria Capurro, et al.
Pageof 8